|
LIG4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75974999999662E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.278390E-03 |
| Normal-vs-Stage2 |
1.777620E-03 |
| Normal-vs-Stage3 |
8.80959999949305E-07 |
| Normal-vs-Stage4 |
6.4952000000007E-05 |
| Stage1-vs-Stage2 |
5.139200E-01 |
| Stage1-vs-Stage3 |
2.604500E-03 |
| Stage1-vs-Stage4 |
8.153700E-02 |
| Stage2-vs-Stage3 |
1.589150E-01 |
| Stage2-vs-Stage4 |
4.953600E-01 |
| Stage3-vs-Stage4 |
4.937600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15969999999288E-05 |
| Normal-vs-AfricanAmerican |
1.183640E-01 |
| Normal-vs-Asian |
4.844700E-03 |
| Caucasian-vs-AfricanAmerican |
2.459600E-01 |
| Caucasian-vs-Asian |
9.787400E-01 |
| AfricanAmerican-vs-Asian |
3.814000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.65030000004651E-06 |
| Normal-vs-Female |
8.41150000000512E-05 |
| Male-vs-Female |
3.462800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.102300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.73343999999576E-05 |
| Normal-vs-Age(61-80Yrs) |
6.23389999954149E-07 |
| Normal-vs-Age(81-100Yrs) |
3.126600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.515600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.187000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.228800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.157800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.452200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.664100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.073900E-02 |
| Classical-VS-Follicular |
1.049580E-01 |
| Classical-VS-Other |
5.060200E-01 |
| Classical-VS-Normal |
7.821300E-04 |
| Tall-VS-Follicular |
2.535600E-01 |
| Tall-VS-Other |
7.072200E-01 |
| Tall-VS-Normal |
1.67278999999576E-05 |
| Follicular-VS-Other |
8.031800E-01 |
| Follicular-VS-Normal |
1.017700E-04 |
| Other-VS-Normal |
5.847600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74139999997713E-06 |
| Normal-vs-N1 |
4.784900E-04 |
| N0-vs-N1 |
3.481600E-01 |
|
|
